iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB) Stock Price Up 0.9% – Here’s Why

iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBGet Free Report) were up 0.9% during mid-day trading on Monday . The stock traded as high as $35.28 and last traded at $35.26. 11,591 shares traded hands during trading, a decline of 38% from the average session volume of 18,793 shares. The stock had previously closed at $34.95.

iShares LifePath Target Date 2030 ETF Stock Performance

The stock’s 50 day simple moving average is $35.15 and its two-hundred day simple moving average is $34.51. The firm has a market capitalization of $81.71 million, a PE ratio of 20.07 and a beta of 0.57.

Hedge Funds Weigh In On iShares LifePath Target Date 2030 ETF

An institutional investor recently raised its position in iShares LifePath Target Date 2030 ETF stock. Capital Advisors Ltd. LLC raised its stake in iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBFree Report) by 21.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,430 shares of the company’s stock after buying an additional 613 shares during the quarter. Capital Advisors Ltd. LLC owned approximately 0.19% of iShares LifePath Target Date 2030 ETF worth $112,000 at the end of the most recent quarter.

iShares LifePath Target Date 2030 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2030 ITDB was launched on Oct 17, 2023 and is issued by BlackRock.

Further Reading

Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.